From August 17, 2022 to September 22, 2022, the company has repurchased 41,771 shares, representing 0.7% for KRW 5,084.38 million. With this, the company has completed the repurchase of 41,771 shares, representing 0.7% for KRW 5,084.38 million under the buyback announced on August 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
137,000 KRW | -2.91% | -0.22% | -43.15% |
03-21 | Medy-Tox Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | South Korean Shares Close Marginally Lower on North Korea's Artillery Shells Firing | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.15% | 673M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- A086900 Stock
- News Medy-Tox Inc.
- Tranche Update on Medy-Tox Inc.'s Equity Buyback Plan announced on August 17, 2022.